Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study validates non-invasive TB test
Badger close up
Badgers intermittently shed M.Bovis cells in sputum, feces and urine, creating a source of potential infection for other badgers and cattle.

PCR testing would remove ethical concerns related to trapping 

A non-invasive procedure which allows for TB infections in badger populations to be monitored without trapping has been validated in a study led by the University of Warwick.

New research, published in the Journal of Clinical Microbiology, shows that PCR testing of badger latrines is as effective, if not more, than current methods of detecting the disease in badger populations.

The procedure allows scientists to gather data on the distribution of the disease over a larger area, which is easier and more cost-effective than trapping. The non-invasive method also removes the ethical concerns related to trapping.

Monitoring Mycobacterium bovis, the bacteria which causes bovine tuberculosis, is important for understanding the location and spread of TB and directing control efforts.

Once infected, badgers intermittently shed M.Bovis cells in sputum, feces and urine, creating a source of potential infection for other badgers and cattle. The bacteria can last outside its host for up to 21 months and has been found in badger setts and latrines.

However, monitoring M.bovis in live badgers is tricky. The current method involves a combination of trapping and diagnosis with immunoassays and cultures of clinical samples. This is not only expensive, but also logistically challenging and likely to result in limited sample sizes.

In the study, the researchers focussed on quantifying fecal shedding of M.bovis cells among badgers using an existing quantitive PCR test. They collected 12 fecal samples from latrines associated with 12 badger social groups in a park in Glouscestershire.

To determine the performance of the PCR test, the scientists compared results to those from immunoassays and culture for clinical samples obtained during routine trapping and sampling of the same badgers.

They found that PCR testing is likely to be as sensitive, or more so, than live testing in M.bovis in badger populations. This indicates that PCR testing could be used as an alternative or compliment immunoassays and clinical samples.

The study also found that PCR testing had greater odds of finding positive samples. However, some badger social groups required more than 20 samples to be collected over a year to detect fecal shedding. 

The researchers say that in order to identify all positive social groups, two separate sampling sessions would be required - one in early summer and the other in late summer. This is due to the intermittent nature of M.bovis shedding and the fact that a wider window of sampling is required to obtain fecal samples from a large proportion of badgers in each social group.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.